Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
What it means for you: You can rely on Syntegon for all output ranges from semi-automatic assembly for small batches to fully-automated high-speed lines
Most patients recover fully if treatment is initiated promptly
not FDA-approved as of January 2025 Best Phase 2 result / 24.2% mean body weight loss at 48 weeks (12 mg dose, N=338 trial) Extended estimate / 28.7% mean weight loss projected at 68 weeks in Phase 2 modeling Dosing schedule / Once weekly subcutaneous injection (doses 1 mg through 12 mg tested) Comparator benchmark / Semaglutide 2.4 mg: 14.9% at 68 weeks (STEP-1, N=1,961) Comparator benchmark / Tirzepatide 15 mg: 20.9% at 72 weeks (SURMOUNT-1, N=2,539) Primary side effects / Nausea, vomiting, diarrhea, constipation (dose-dependent) Phase 3 status / Phase 3 program (TRIUMPH trials) enrolling as of 2024 Manufacturer / Eli Lilly and Company What Is Retatrutide
Rats receiving BPC-157 after partial hepatectomy showed accelerated liver regeneration, measured by increased Ki-67 proliferation indices and earlier normalization of liver mass compared with controls [7]
The buyer is solely responsible for compliance with all applicable laws, institutional biosafety guidelines, and research-use regulations
US$ 21.56
US$ 25.52
US$ 24.64
US$ 23.08
US$ 20.18
US$ 27.26
